GlassScriptPhysician profile
Alan Jeffrey Torrey
NPI 1750693206
$30,088.38
in general payments reported to CMS, 2019-2025
20 companies · $628 in 2025
The $628 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,090 · 2020: $4,203 · 2021: $4,589 · 2022: $5,191 · 2023: $1,836 · 2024: $11K · 2025: $628.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $9,600 · Food and Beverage: $3,402 · Entertainment: $13.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $9,600.00 |
| Food and Beverage | $3,401.99 |
| Entertainment | $13.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $24,968.40 | 2019-2025 | Proclaim, Prodigy, Eterna |
| Medtronic, INC. | $1,623.49 | 2021-2024 | Intellis Adaptivestim, Accurian |
| Vertiflex, INC. | $1,584.22 | 2019 | |
| Boston Scientific Corporation | $656.72 | 2019-2025 | Intracept, Wavewriter Alpha Prime 16, General - Pain Management |
| Foundation Fusion Solutions, LLC | $229.69 | 2023-2024 | |
| Relievant Medsystems, INC. | $199.65 | 2021-2022 | |
| Spinal Simplicity, LLC | $168.51 | 2022-2023 | Ha Minuteman G3-R |
| Mdd US Operations, LLC | $125.00 | 2019 | |
| Medtronic USA, INC. | $99.87 | 2019-2020 | |
| Biotronik Nro, INC. | $85.26 | 2025 | Prospera |
| Kowa Pharmaceuticals America, INC. | $61.77 | 2022-2023 | Seglentis |
| Surgentec | $58.15 | 2023 | Ion Facet Screw System, Tilink |
| Vertos Medical, INC. | $49.53 | 2024 | Mild Device Kit |
| Pfizer INC. | $49.40 | 2019-2020 | |
| Nevro Corp. | $40.87 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biodelivery Sciences International, INC. | $23.82 | 2021 | |
| Grt US Holding, INC. | $20.01 | 2022 | |
| Collegium Pharmaceutical, INC. | $15.44 | 2021 | |
| Glaxosmithkline, LLC. | $14.86 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $13.72 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Torrey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.